Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

136
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
136
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

405
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
405
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

682
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
682
Drug Nomenclature01:17

Drug Nomenclature

1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K
Healthcare Agencies II01:17

Healthcare Agencies II

678
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
678

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

On Sanitary Sovereignty in the Health Industrial Complex.

Ciencia & saude coletiva·2023
Same author

New challenges in health technology assessment (HTA): the case of Zolgensma.

Ciencia & saude coletiva·2023
Same author

Towards an industrial policy for expanding access to health.

Ciencia & saude coletiva·2022
Same author

Health Science, Technology and Innovation Policy (ST&I/H): an update for debate.

Ciencia & saude coletiva·2021
Same author

The Butantan Institute and the Brazilian AntiCOVID Vaccine.

Ciencia & saude coletiva·2021
Same author

Vaccines: From Public Health to Big Business.

Ciencia & saude coletiva·2021

相关实验视频

Updated: May 28, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.3K

关于制药公司和大制药公司

Reinaldo Guimarães1

  • 1Núcleo de Bioética e Ética Aplicada, Universidade Federal do Rio de Janeiro. R. Venceslau Brás 71, Campus Praia Vermelha, Botafogo. 22290-140 Rio de Janeiro RJ Brasil. reinaldo.guimaraes47@gmail.com.

Ciencia & saude coletiva
|February 12, 2025
PubMed
概括
此摘要是机器生成的。

全球制药业因经济金融化和知识产权变化而演变为大药业. 这种转变削弱了二战后的多边主义.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
05:46

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

Published on: August 1, 2018

13.0K

相关实验视频

Last Updated: May 28, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
05:46

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

Published on: August 1, 2018

13.0K

科学领域:

  • 卫生经济学 卫生经济学
  • 政治经济学就是政治经济学.
  • 制药行业分析 制药行业分析

背景情况:

  • 全球制药行业演变为"大药业"是一个重要的经济和政治现象.
  • 了解"健康产业综合体"对于分析医疗保健系统至关重要.
  • 第二次世界大战后的多边秩序在20世纪90年代面临挑战.

研究的目的:

  • 分析全球制药行业向大药业的发展轨迹.
  • 检查卫生产业综合体的经济和政治层面.
  • 确定推动该行业转型的关键决定因素及其与全球政治转变的关系.

主要方法:

  • 分析有关制药行业的经济和政治文献.
  • 审查金融化对全球政治经济的影响.
  • 审查世界贸易组织的TRIPS协议和知识产权协调.

主要成果:

  • 金融化和知识产权协调 (TRIPS协议) 是大制药公司起的关键驱动力.
  • 制药公司内部的微观经济变化重塑了生产过程.
  • 该行业的转型与二战后多边机构的削弱有关.

结论:

  • 大制药公司的起与全球经济和政治重组密切相关.
  • 知识产权制度和金融化是制药行业整合的关键因素.
  • 大制药公司的演变意味着更广泛的全球治理和代表性的转变趋势.